new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Glaxosmithkline Intellectual Property no 2 Limited patents

Recent patent applications related to Glaxosmithkline Intellectual Property no 2 Limited. Glaxosmithkline Intellectual Property no 2 Limited is listed as an Agent/Assignee. Note: Glaxosmithkline Intellectual Property no 2 Limited may have other listings under different names/spellings. We're not affiliated with Glaxosmithkline Intellectual Property no 2 Limited, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glaxosmithkline Intellectual Property no 2 Limited-related inventors




Date Glaxosmithkline Intellectual Property no 2 Limited patents (updated weekly) - BOOKMARK this page
03/16/17Chemical compounds
03/02/17Pyrrolo[3,2-d]pyrimidine derivatives as inducers of human interferon
02/02/17Enhancer of zeste homolog 2 inhibitors
01/19/17Enhancer of zeste homolog 2 inhibitors
12/29/16Fatty acid synthase inhibitors
12/15/16Methods of treating cancer patients responding to ezh2 inhibitor gsk126
11/24/16Hydroxy formamide derivatives and their use
11/17/16Crystalline forms
09/15/16Hydrobromide salt ofn-(4-chloro-2-hydroxy-3-((3s)-3-piperidinylsulfonyl)phenyl-n'-(3-fluoro-2-methylphenyl)urea
09/01/16Tricyclic benzoxaborole compounds and uses thereof
08/04/16Cyclopropylamines as lsd1 inhibitors
08/04/16Losmapimod for use in treating glomerular disease
07/14/16Novel compounds as diacylglycerol acyltransferase inhibitors
06/16/16Process for preparing benzoxaboroles
05/19/16Methods for determining total body skeletal muscle mass
05/19/16Novel assay
05/12/16Enhancer of zeste homolog 2 inhibitors
05/05/16Enhancer of zeste homolog 2 inhibitors
04/21/16Methods of treating cancer
04/14/16Enhancer of zeste homolog 2 inhibitors
03/17/16Method of treatment
03/10/16Novel use
03/10/16Methods of treating cancer
01/28/16Methods for purifying antibodies
01/21/162,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
01/21/16Furopyridines as bromodomain inhibitors
01/07/16Low concentration antibody formulations
12/03/15Combination
11/19/15Fatty acid synthase inhibitors
08/13/15Novel compounds as diacylglycerol acyltransferase inhibitors
03/26/15Treatment steroid responsive dermatoses
03/19/15Chemical compounds
02/19/15Pi3k inhibitors for treating fibrotic diseases
01/29/15Pi3k inhibitors for treating cough
12/25/14Methods of treatment
12/25/14Novel compounds as diacylglycerol acyltransferase inhibitors
12/18/14Cyclopropylamines as lsd1 inhibitors
12/04/14New compounds
11/06/14Therapeutic peptides
08/07/14Method of administration and treatment
06/19/14Method of selecting therapeutic indications
06/05/14Novel pharmaceutical composition
03/20/14Novel compounds as diacylglycerol acyltransferase inhibitors
09/05/13Methods of treating cancer
09/05/13Method of treatment with braf inhibitor
08/22/13Methods for treating cancer







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glaxosmithkline Intellectual Property no 2 Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glaxosmithkline Intellectual Property no 2 Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';